Discussion over the safety of contraceptive pills has been asked for by the Food and Drug Administration. Contraceptive pills containing drospirenone have attracted controversies as it has been found that the contraceptive pills containing drospirenone can cause blood clots.

Previously, the side effects of the contraceptive pills were suppressed by its benefits. Before allowing a drug to be available in the market for sale, the FDA often seeks advice from its advisors. However, it is not necessary that it does take account of the advices of advisors.

However, recently, the advisory committee of the FDA has asked it to reconsider the benefits of the contraceptive pills. The FDA Commissioner, Margaret Hamburg, received a letter from the advisors asking her to re-conduct votes on the controversial contraceptive pill.

A study conducted by the FDA has found that 10 in 10,000 women taking contraceptive pills containing drospirenone experience blood clot every year. Blood clot can be hazardous for health if they reach to lung, heart or brain.

Thee concerned consumer groups have asked the FDA authorities to recall the products from the market as they pose risk to the lives of women. In a review conducted over the drug, the FDA recommended that the contraceptive pills containing drospirenone should carry heavy warnings.

It is hoped that soon the authorities concerned would be able to take a decision over the controversial contraceptive pill. The priority should be given to the health of women before allowing any contraceptive pill to be available in the market.

A contraceptive pill not only prevents unwanted pregnancy but also affects the hormones of woman. The contraceptive pills can have direct affect on the reproductive system of woman. Therefore, decision regarding the contraceptive pills should be taken smartly.